Clinical Analysis of Video Assisted Thoracic Surgery for the Treatment of Thoracic Empyema.
- Author:
Sang Gi OH
1
;
Sang Yun SONG
;
Chi Hyeong YUN
;
Kook Ju NA
;
Kang Eun KONG
;
Song Ran PARK
;
Sang Hyung KIM
Author Information
1. Department of Thoracic and Cardiovascular Surgery, Chonnam National University Hospital, Korea.
- Publication Type:Original Article
- Keywords:
Empyema;
Pleural effusion;
Thoracoscopy
- MeSH:
Anti-Bacterial Agents;
Drainage;
Empyema;
Empyema, Pleural;
Follow-Up Studies;
Humans;
Pleural Effusion;
Thoracic Surgery, Video-Assisted;
Thoracoscopy;
Thoracotomy
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
2010;43(2):139-143
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Thoracic empyema remains a serious problem despite the availability of modern diagnostic methods and appropriate antibiotics. The condition presents in many different forms and stages that require different therapeutic options. Video-assisted thoracic surgery (VATS) has become increasingly popular for use in the treatment of empyema. MATERIAL AND METHOD: From January 2005 to May 2009, VATS was performed in 36 patients with pleural empyema and for whom chest-tube drainage and antibiotic therapy had failed or the CT scan showed multiseptate disease. The perioperative clinical factors were analyzed for all the study patients. RESULT: All the patients underwent VATS, but it was necessary to convert to thoracotomy in one patient. The mean operation time was 90+/-38.5 min. For the operative evaluation, 11 patients were compatible with ATS stage III. The duration of chest-tube insertion was 11.9+/-5.8 (3~24) days. One patient did not improve and therefore this patient underwent additional open drainage. At discharge, costophrenic angle blunting was observed in 22 patients, pleural thickening was noted in 20 patients, both were noted in 17 patients and neither was noted in 11 patients. However, at follow-up, each of these changes was observed in 9, 7, 4 and 24 patients, respectively. All except one patient showed radiographic improvement. CONCLUSION: VATS is suitable for the treatment of early and fibrinopurulent thoracic empyema, and even in selected patients with stage III disease.
